Equitable Trust Co. cut its holdings in shares of National Health Investors Inc (NYSE:NHI) by 33.3% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 4,190 shares of the real estate investment trust’s stock after selling 2,095 shares during the quarter. Equitable Trust Co.’s holdings in National Health Investors were worth $341,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also bought and sold shares of NHI. ERTS Wealth Advisors LLC purchased a new position in shares of National Health Investors during the 4th quarter valued at approximately $25,000. Marshall Wace North America L.P. purchased a new position in shares of National Health Investors during the 1st quarter valued at approximately $31,000. Samalin Investment Counsel LLC purchased a new stake in National Health Investors in the 4th quarter worth $40,000. Duncker Streett & Co. Inc. purchased a new stake in National Health Investors in the 4th quarter worth $46,000. Finally, Meeder Asset Management Inc. purchased a new stake in National Health Investors in the 4th quarter worth $52,000. 70.65% of the stock is owned by institutional investors.
NHI traded up $1.74 on Thursday, hitting $50.51. 44,190 shares of the company’s stock were exchanged, compared to its average volume of 601,443. National Health Investors Inc has a fifty-two week low of $31.37 and a fifty-two week high of $91.12. The company has a current ratio of 16.40, a quick ratio of 16.40 and a debt-to-equity ratio of 0.96. The firm has a 50-day moving average price of $74.37 and a 200-day moving average price of $80.39. The stock has a market cap of $1.91 billion, a price-to-earnings ratio of 13.76 and a beta of 0.35.
National Health Investors (NYSE:NHI) last announced its quarterly earnings results on Wednesday, February 19th. The real estate investment trust reported $0.95 earnings per share for the quarter, missing the consensus estimate of $1.41 by ($0.46). National Health Investors had a net margin of 50.44% and a return on equity of 11.07%. The firm had revenue of $82.20 million for the quarter, compared to analyst estimates of $79.92 million. During the same period in the previous year, the firm posted $1.35 EPS. The company’s revenue was up 11.1% compared to the same quarter last year. On average, equities analysts predict that National Health Investors Inc will post 5.69 EPS for the current year.
The company also recently announced a quarterly dividend, which will be paid on Friday, May 8th. Investors of record on Tuesday, March 31st will be paid a dividend of $1.1025 per share. This represents a $4.41 dividend on an annualized basis and a dividend yield of 8.73%. This is a positive change from National Health Investors’s previous quarterly dividend of $1.05. The ex-dividend date is Monday, March 30th. National Health Investors’s dividend payout ratio is presently 76.36%.
In other news, Director W Andrew Adams bought 27,000 shares of the business’s stock in a transaction that occurred on Monday, March 23rd. The shares were purchased at an average cost of $36.16 per share, for a total transaction of $976,320.00. Following the completion of the purchase, the director now owns 759,784 shares of the company’s stock, valued at $27,473,789.44. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO D. Eric Mendelsohn sold 4,000 shares of the company’s stock in a transaction that occurred on Monday, February 24th. The stock was sold at an average price of $90.58, for a total transaction of $362,320.00. Following the sale, the chief executive officer now owns 44,256 shares in the company, valued at $4,008,708.48. The disclosure for this sale can be found here. 5.11% of the stock is currently owned by corporate insiders.
Several equities research analysts recently commented on the stock. Berenberg Bank assumed coverage on shares of National Health Investors in a report on Wednesday, February 5th. They issued a “buy” rating and a $94.00 price target for the company. BMO Capital Markets raised shares of National Health Investors from an “underperform” rating to a “market perform” rating and boosted their price target for the stock from $74.00 to $82.00 in a report on Tuesday, January 7th. Wells Fargo & Co cut their price target on shares of National Health Investors from $82.00 to $51.00 and set an “equal weight” rating for the company in a report on Thursday. Finally, Mizuho reaffirmed a “buy” rating and set a $95.00 target price on shares of National Health Investors in a research note on Friday, December 20th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus price target of $82.40.
National Health Investors Profile
Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
Featured Story: How is Preferred Stock Different from Common Stock?
Want to see what other hedge funds are holding NHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Health Investors Inc (NYSE:NHI).
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.